SCHEMBL20102464

SCHEMBL20102464

CCCCCc1ccc(COc2cc3c(c(F)c2F)-c2c-3ccc(OCC)c2F)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMPD1 P17405 2/20 0.41
TACR2 P21452 3/20 0.36
ESR1 P03372 2/20 0.36
ADRA2A P08913 2/20 0.36
ADORA3 P0DMS8 2/20 0.36
SLC6A2 P23975 2/20 0.36
SLC6A4 P31645 2/20 0.36
SLC6A3 Q01959 2/20 0.36
HRH3 Q9Y5N1 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
SHBG P04278 1/20 0.36
TP53 P04637 1/20 0.36
CYP3A4 P08684 1/20 0.36
HSPD1 P10809 1/20 0.36
ADRB3 P13945 1/20 0.36
HTR2C P28335 1/20 0.36
HSPE1 P61604 1/20 0.36
HIF1A Q16665 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20102522 0.88 SMPD1 (0.41) SMPD1TACR2ESR1ADRA2AADORA3
SCHEMBL20102437 0.86 RARB (0.43) KDM4EALDH1A1LMNACYP3A4HSD17B10
SCHEMBL20117611 0.85 GAA (0.46) TACR2KDM4EALDH1A1LMNATP53
SCHEMBL20111640 0.84 HTR1A (0.45) SLC6A2SLC6A4SLC6A3KDM4EALDH1A1
SCHEMBL20102390 0.83 L3MBTL1 (0.42) ALDH1A1MAPTRAB9AL3MBTL1GAA
SCHEMBL12740941 0.83 RARB (0.43) SMPD1TACR2ESR1ADRA2AADORA3
SCHEMBL12736486 0.83 RARB (0.43) SMPD1TACR2ESR1ADRA2AADORA3
SCHEMBL20102438 0.82 RARB (0.37) RARBMAPTRAB9AL3MBTL1
SCHEMBL20102405 0.81 FGFR2 (0.34) ALDH1A1TP53CYP3A4PTGS2MAPT
SCHEMBL20102550 0.79 RARB (0.38) KDM4EALDH1A1HSD17B10RARBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180119009-A1 LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180119009-A1 LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE YBX1, PIEZO1, C1S SMPD1 4151/4885TACR2 2371/4885ESR1 1005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.